The era of serum prostate specific antigen as a marker for biopsy of the prostate and detecting prostate cancer is now over in the USA

BJU International

Volumn 94, Issue 7, 2004, Pages 963-964

  Stamey, Thomas A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

AUTOPSY; CANCER DIAGNOSIS; CANCER GRADING; CANCER MORTALITY; CANCER RADIOTHERAPY; DIAGNOSTIC ACCURACY; HISTOPATHOLOGY; HUMAN; MALE; MULTIPLE REGRESSION; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; AGE DISTRIBUTION; AGED; BIOPSY; HUMANS; MALE; MIDDLE AGED; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; UNITED STATES;

EID: 9644282966     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2004.05212.x     Document Type: Note

References (9)

1. Stamey TA,Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. New Engl J Med, 1987; 317: 909-16
2. Stamey TA, Kabalin JN, McNeal JE et al. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients. J Urol 1989; 141: 1076-83
3. Stamey TA, McNeal JE, Yemoto CM, Sigal BM, Johnstone IM. Biological determinants of cancer progression in men with prostate cancer. J Am Med Assoc 1999; 281: 1395-400
4. Stamey TA, Johnstone IM, McNeal JE, Lu AY, Yemoto CM. Preoperative serum PSA levels between 2 and 22 ng/ml correlate poorly with post-radical prostatectomy cancer morphology; PSA cure rates appear constant between 2 and 9 ng/ml. J Urol 2002; 167: 103-11
5. Stamey TA, Caldwell M, McNeal JE, Nolley R, Hemenez M, Downs J. The PSA era in the United States is over for prostate cancer: what happened in the past 20 Years? J Urol 2004; in press
6. Stewart CS, Leibovich BC, Weaver AL, Lieber M. M: Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol 2001; 166: 86-92
7. Sakr WA, Grignon DJ, Haas GP, Heilbrun LK, Pontes JE, Crissman JD. Age and racial distribution of prostatic intraepithelial neoplasia. Eur Urol 1996; 30: 138-44
8. Roehrborn CG, McConnell J, Bonilla J, Rosenblatt S, Hudson PB. Serum prostate specific antigen is a strong predictor of future prostate growth in men with benign prostatic hyperplasia. J Urol 2000; 163: 13-20
9. Ries LAG, Eisner MP, Kosary CL et al. National Cancer Institute, Bethesda, MD, 2003. http://seer.cancer.gov./csr/ 1975_2000